"The development of better diagnostic tools, and in turn treatment plans, requires a better understanding of the cell and molecular mechanisms underlying Alzheimer’s disease. It also requires the identification of more specific and robust biomarkers related to these mechanisms.”
- Jordan Hirschfeld, Associate Development Scientist, CST